

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.63922195 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 4.63922195 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.36833448 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 4.36833448 |
| 5 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.35630547 |
| 6 | protein carboxylation (GO:0018214) | 4.35630547 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 4.21952675 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.10660610 |
| 9 | negative regulation of complement activation (GO:0045916) | 3.91522705 |
| 10 | complement activation, alternative pathway (GO:0006957) | 3.89581289 |
| 11 | tryptophan metabolic process (GO:0006568) | 3.80507592 |
| 12 | tryptophan catabolic process (GO:0006569) | 3.80060361 |
| 13 | indole-containing compound catabolic process (GO:0042436) | 3.80060361 |
| 14 | indolalkylamine catabolic process (GO:0046218) | 3.80060361 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.79351562 |
| 16 | glyoxylate metabolic process (GO:0046487) | 3.79161596 |
| 17 | oligosaccharide catabolic process (GO:0009313) | 3.78618898 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.77039905 |
| 19 | cell adhesion mediated by integrin (GO:0033627) | 3.74246614 |
| 20 | negative regulation of protein activation cascade (GO:2000258) | 3.73658079 |
| 21 | sulfur amino acid catabolic process (GO:0000098) | 3.73359970 |
| 22 | regulation of protein activation cascade (GO:2000257) | 3.71811775 |
| 23 | bile acid biosynthetic process (GO:0006699) | 3.66146875 |
| 24 | cysteine metabolic process (GO:0006534) | 3.61879339 |
| 25 | regulation of complement activation (GO:0030449) | 3.61197212 |
| 26 | kynurenine metabolic process (GO:0070189) | 3.48590552 |
| 27 | negative regulation of fibrinolysis (GO:0051918) | 3.47906322 |
| 28 | urea metabolic process (GO:0019627) | 3.45986332 |
| 29 | urea cycle (GO:0000050) | 3.45986332 |
| 30 | detection of molecule of bacterial origin (GO:0032490) | 3.45497952 |
| 31 | homocysteine metabolic process (GO:0050667) | 3.44073094 |
| 32 | iron ion import (GO:0097286) | 3.42448208 |
| 33 | plasma lipoprotein particle clearance (GO:0034381) | 3.39618595 |
| 34 | high-density lipoprotein particle remodeling (GO:0034375) | 3.38841614 |
| 35 | cellular glucuronidation (GO:0052695) | 3.34676116 |
| 36 | reverse cholesterol transport (GO:0043691) | 3.29742101 |
| 37 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.28775922 |
| 38 | amino-acid betaine metabolic process (GO:0006577) | 3.26625426 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.25755757 |
| 40 | glucuronate metabolic process (GO:0019585) | 3.23261386 |
| 41 | uronic acid metabolic process (GO:0006063) | 3.23261386 |
| 42 | membrane raft organization (GO:0031579) | 3.21995593 |
| 43 | phospholipid efflux (GO:0033700) | 3.21297221 |
| 44 | tyrosine metabolic process (GO:0006570) | 3.20770714 |
| 45 | glycosphingolipid catabolic process (GO:0046479) | 3.20107609 |
| 46 | lysine catabolic process (GO:0006554) | 3.18282279 |
| 47 | lysine metabolic process (GO:0006553) | 3.18282279 |
| 48 | plasma lipoprotein particle remodeling (GO:0034369) | 3.18186447 |
| 49 | protein-lipid complex remodeling (GO:0034368) | 3.18186447 |
| 50 | macromolecular complex remodeling (GO:0034367) | 3.18186447 |
| 51 | keratan sulfate catabolic process (GO:0042340) | 3.17378308 |
| 52 | fibrinolysis (GO:0042730) | 3.17276599 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.16204732 |
| 54 | Golgi transport vesicle coating (GO:0048200) | 3.15836737 |
| 55 | COPI coating of Golgi vesicle (GO:0048205) | 3.15836737 |
| 56 | nitrogen cycle metabolic process (GO:0071941) | 3.15474674 |
| 57 | bile acid metabolic process (GO:0008206) | 3.13486341 |
| 58 | protein localization to endosome (GO:0036010) | 3.11394449 |
| 59 | drug transmembrane transport (GO:0006855) | 3.07120518 |
| 60 | urate metabolic process (GO:0046415) | 3.06581512 |
| 61 | aromatic amino acid family metabolic process (GO:0009072) | 3.04916309 |
| 62 | regulation of cholesterol esterification (GO:0010872) | 3.04434381 |
| 63 | negative regulation of humoral immune response (GO:0002921) | 3.03641351 |
| 64 | valine metabolic process (GO:0006573) | 3.01851431 |
| 65 | cholesterol efflux (GO:0033344) | 2.99447415 |
| 66 | macroautophagy (GO:0016236) | 2.97129411 |
| 67 | aldehyde catabolic process (GO:0046185) | 2.96014965 |
| 68 | positive regulation of blood coagulation (GO:0030194) | 2.94094780 |
| 69 | positive regulation of hemostasis (GO:1900048) | 2.94094780 |
| 70 | phospholipid homeostasis (GO:0055091) | 2.89557708 |
| 71 | low-density lipoprotein particle remodeling (GO:0034374) | 2.89161067 |
| 72 | glycolipid catabolic process (GO:0019377) | 2.87926972 |
| 73 | lipoprotein metabolic process (GO:0042157) | 2.87755058 |
| 74 | positive regulation of coagulation (GO:0050820) | 2.87376365 |
| 75 | opsonization (GO:0008228) | 2.86385180 |
| 76 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.84589704 |
| 77 | triglyceride homeostasis (GO:0070328) | 2.84559769 |
| 78 | acylglycerol homeostasis (GO:0055090) | 2.84559769 |
| 79 | serine family amino acid catabolic process (GO:0009071) | 2.82752534 |
| 80 | benzene-containing compound metabolic process (GO:0042537) | 2.81144993 |
| 81 | COPII vesicle coating (GO:0048208) | 2.80233845 |
| 82 | bile acid and bile salt transport (GO:0015721) | 2.77341859 |
| 83 | indolalkylamine metabolic process (GO:0006586) | 2.77041050 |
| 84 | low-density lipoprotein particle clearance (GO:0034383) | 2.76560983 |
| 85 | regulation of cholesterol storage (GO:0010885) | 2.74499858 |
| 86 | response to peptidoglycan (GO:0032494) | 2.73744926 |
| 87 | positive regulation of lipid catabolic process (GO:0050996) | 2.72881427 |
| 88 | cellular modified amino acid catabolic process (GO:0042219) | 2.72626139 |
| 89 | regulation of beta-amyloid formation (GO:1902003) | 2.71939979 |
| 90 | skin morphogenesis (GO:0043589) | 2.71606398 |
| 91 | plasma lipoprotein particle assembly (GO:0034377) | 2.70747530 |
| 92 | response to thyroid hormone (GO:0097066) | 2.70500617 |
| 93 | complement activation (GO:0006956) | 2.69236721 |
| 94 | ethanol oxidation (GO:0006069) | 2.69056265 |
| 95 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.68810199 |
| 96 | amine catabolic process (GO:0009310) | 2.67898463 |
| 97 | cellular biogenic amine catabolic process (GO:0042402) | 2.67898463 |
| 98 | plasma lipoprotein particle organization (GO:0071827) | 2.67580149 |
| 99 | alpha-amino acid catabolic process (GO:1901606) | 2.67523521 |
| 100 | carnitine metabolic process (GO:0009437) | 2.67511736 |
| 101 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.67386142 |
| 102 | response to nitrosative stress (GO:0051409) | 2.66386178 |
| 103 | fatty acid oxidation (GO:0019395) | 2.65679652 |
| 104 | lipid oxidation (GO:0034440) | 2.64649355 |
| 105 | acute-phase response (GO:0006953) | 2.63758343 |
| 106 | fatty acid beta-oxidation (GO:0006635) | 2.63349041 |
| 107 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.62781242 |
| 108 | epoxygenase P450 pathway (GO:0019373) | 2.62517062 |
| 109 | cellular copper ion homeostasis (GO:0006878) | 2.62314379 |
| 110 | negative regulation of sterol transport (GO:0032372) | 2.62145532 |
| 111 | negative regulation of cholesterol transport (GO:0032375) | 2.62145532 |
| 112 | protein-lipid complex subunit organization (GO:0071825) | 2.62140655 |
| 113 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.61352185 |
| 114 | protein-lipid complex assembly (GO:0065005) | 2.61027582 |
| 115 | sterol homeostasis (GO:0055092) | 2.60729859 |
| 116 | cholesterol homeostasis (GO:0042632) | 2.60476208 |
| 117 | hemidesmosome assembly (GO:0031581) | 2.60229901 |
| 118 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.59372774 |
| 119 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.59372774 |
| 120 | complement activation, classical pathway (GO:0006958) | 2.58264460 |
| 121 | xenobiotic catabolic process (GO:0042178) | 2.57662632 |
| 122 | negative regulation of response to reactive oxygen species (GO:1901032) | 2.57113240 |
| 123 | drug transport (GO:0015893) | 2.56771340 |
| 124 | protein activation cascade (GO:0072376) | 2.56150843 |
| 125 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.54666021 |
| 126 | regulation of cholesterol metabolic process (GO:0090181) | 2.54491764 |
| 127 | ceramide catabolic process (GO:0046514) | 2.53507908 |
| 128 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.49343490 |
| 129 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.48673098 |
| 130 | neutrophil activation involved in immune response (GO:0002283) | 2.48238097 |
| 131 | positive regulation of macrophage cytokine production (GO:0060907) | 2.48014450 |
| 132 | regulation of macrophage cytokine production (GO:0010935) | 2.43797831 |
| 133 | detection of external biotic stimulus (GO:0098581) | 2.42956946 |
| 134 | macrophage activation involved in immune response (GO:0002281) | 2.40000482 |
| 135 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38455333 |
| 136 | positive regulation of extracellular matrix organization (GO:1903055) | 2.35710907 |
| 137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.34231794 |
| 138 | membrane lipid catabolic process (GO:0046466) | 2.30519102 |
| 139 | sphingolipid catabolic process (GO:0030149) | 2.30358604 |
| 140 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.30083573 |
| 141 | desmosome organization (GO:0002934) | 2.28657962 |
| 142 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.27484352 |
| 143 | trivalent inorganic cation transport (GO:0072512) | 2.26304191 |
| 144 | ferric iron transport (GO:0015682) | 2.26304191 |
| 145 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.26282906 |
| 146 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.26003250 |
| 147 | amyloid precursor protein catabolic process (GO:0042987) | 2.25289818 |
| 148 | macrophage activation (GO:0042116) | 2.24535367 |
| 149 | import into cell (GO:0098657) | 2.24525792 |
| 150 | sphingosine metabolic process (GO:0006670) | 2.22907584 |
| 151 | transferrin transport (GO:0033572) | 2.22732290 |
| 152 | positive regulation of receptor recycling (GO:0001921) | 2.21185899 |
| 153 | amino sugar catabolic process (GO:0046348) | 2.20404677 |
| 154 | positive regulation of actin filament depolymerization (GO:0030836) | 2.19631851 |
| 155 | negative regulation of interleukin-17 production (GO:0032700) | 2.19187487 |
| 156 | regulation of cellular amide metabolic process (GO:0034248) | 2.19157352 |
| 157 | membrane budding (GO:0006900) | 2.17381264 |
| 158 | vesicle coating (GO:0006901) | 2.17156361 |
| 159 | amyloid precursor protein metabolic process (GO:0042982) | 2.15503862 |
| 160 | response to methylmercury (GO:0051597) | 2.14591831 |
| 161 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.13621331 |
| 162 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.12855123 |
| 163 | positive regulation of leukocyte degranulation (GO:0043302) | 2.12629498 |
| 164 | apoptotic cell clearance (GO:0043277) | 2.12447898 |
| 165 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.12267532 |
| 166 | protein retention in ER lumen (GO:0006621) | 2.11758118 |
| 167 | regulation of extracellular matrix disassembly (GO:0010715) | 2.11111447 |
| 168 | membrane protein ectodomain proteolysis (GO:0006509) | 2.10950370 |
| 169 | cell wall macromolecule catabolic process (GO:0016998) | 2.10147511 |
| 170 | phagosome maturation (GO:0090382) | 2.09514022 |
| 171 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.09325291 |
| 172 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.08710081 |
| 173 | sequestering of metal ion (GO:0051238) | 2.08699191 |
| 174 | peptide catabolic process (GO:0043171) | 2.07966068 |
| 175 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.07702242 |
| 176 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.07191342 |
| 177 | detection of other organism (GO:0098543) | 2.07161489 |
| 178 | copper ion homeostasis (GO:0055070) | 2.06820619 |
| 179 | chondroitin sulfate catabolic process (GO:0030207) | 2.05923492 |
| 180 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.05183337 |
| 181 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.04709281 |
| 182 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.03698963 |
| 183 | protein hydroxylation (GO:0018126) | 2.01840292 |
| 184 | response to manganese ion (GO:0010042) | 2.01829791 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.84505677 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.07684742 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.35987385 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.24512704 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.06237132 |
| 6 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.66155825 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39894893 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.36555111 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.95866767 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.91677784 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.81965436 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.72731397 |
| 13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.71122077 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.60284086 |
| 15 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.57689983 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56493498 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51100406 |
| 18 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.40494438 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.30575389 |
| 20 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.28784635 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 2.14545508 |
| 22 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.14050545 |
| 23 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13739295 |
| 24 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.04493303 |
| 25 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.02133711 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01189935 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00628690 |
| 28 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.97248594 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.88240654 |
| 30 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88111679 |
| 31 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.82343775 |
| 32 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.76749112 |
| 33 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.76749112 |
| 34 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.68251014 |
| 35 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53366915 |
| 36 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.53350239 |
| 37 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.50890217 |
| 38 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50700112 |
| 39 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50248119 |
| 40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.50198532 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.49561589 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47668694 |
| 43 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47337739 |
| 44 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43651043 |
| 45 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.41627409 |
| 46 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37121539 |
| 47 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.33268281 |
| 48 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32228796 |
| 49 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32182626 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29706283 |
| 51 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29370263 |
| 52 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.28252681 |
| 53 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.26988725 |
| 54 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.24330440 |
| 55 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.23876823 |
| 56 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23740699 |
| 57 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23455449 |
| 58 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21037667 |
| 59 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.20729165 |
| 60 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20350061 |
| 61 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.18360569 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17858095 |
| 63 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.17355592 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16364172 |
| 65 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.13081131 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.12602041 |
| 67 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.11022055 |
| 68 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10915599 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.10388001 |
| 70 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09641686 |
| 71 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06009561 |
| 72 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.06000616 |
| 73 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.05843598 |
| 74 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04486799 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.04188962 |
| 76 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03415060 |
| 77 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.02493549 |
| 78 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.02493549 |
| 79 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02471688 |
| 80 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.02381763 |
| 81 | SPI1_23127762_ChIP-Seq_K562_Human | 1.01646433 |
| 82 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01417612 |
| 83 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.01339693 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.01192485 |
| 85 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.00781645 |
| 86 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00698056 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99996956 |
| 88 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99686941 |
| 89 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99155203 |
| 90 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96765593 |
| 91 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.96121848 |
| 92 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95777277 |
| 93 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95683994 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95588665 |
| 95 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92858392 |
| 96 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92855961 |
| 97 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.92626236 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92333597 |
| 99 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.90757907 |
| 100 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90492795 |
| 101 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90360506 |
| 102 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.89049731 |
| 103 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88427561 |
| 104 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88370913 |
| 105 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.86547139 |
| 106 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.86160305 |
| 107 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.85608498 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.85354387 |
| 109 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85326278 |
| 110 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.85113867 |
| 111 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.84895670 |
| 112 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84236728 |
| 113 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.83355378 |
| 114 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.82259895 |
| 115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79929663 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.78935828 |
| 117 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78859453 |
| 118 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.74129961 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73198868 |
| 120 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.73176132 |
| 121 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.72832641 |
| 122 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.72832641 |
| 123 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.72647032 |
| 124 | * ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72457146 |
| 125 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70829496 |
| 126 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.70151524 |
| 127 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.69405307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.85414761 |
| 2 | MP0005360_urolithiasis | 4.59157179 |
| 3 | MP0005365_abnormal_bile_salt | 3.51482028 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.49681471 |
| 5 | MP0008438_abnormal_cutaneous_collagen | 3.09608291 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.07888858 |
| 7 | MP0003252_abnormal_bile_duct | 2.86971794 |
| 8 | MP0003195_calcinosis | 2.81480506 |
| 9 | MP0009840_abnormal_foam_cell | 2.71174581 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.54017225 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.48666576 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.38918365 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.19451591 |
| 14 | MP0008260_abnormal_autophagy | 2.08782364 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.07364666 |
| 16 | MP0003806_abnormal_nucleotide_metabolis | 2.04973900 |
| 17 | MP0003705_abnormal_hypodermis_morpholog | 1.99056601 |
| 18 | MP0003950_abnormal_plasma_membrane | 1.98072455 |
| 19 | MP0000569_abnormal_digit_pigmentation | 1.97424009 |
| 20 | MP0000920_abnormal_myelination | 1.97083088 |
| 21 | MP0005275_abnormal_skin_tensile | 1.96012582 |
| 22 | * MP0005332_abnormal_amino_acid | 1.93310682 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 1.91087155 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 1.87495901 |
| 25 | MP0003329_amyloid_beta_deposits | 1.82025595 |
| 26 | MP0002254_reproductive_system_inflammat | 1.80864858 |
| 27 | MP0003436_decreased_susceptibility_to | 1.75208074 |
| 28 | MP0005083_abnormal_biliary_tract | 1.74421556 |
| 29 | MP0003724_increased_susceptibility_to | 1.72412763 |
| 30 | MP0003300_gastrointestinal_ulcer | 1.64177185 |
| 31 | MP0001666_abnormal_nutrient_absorption | 1.58279112 |
| 32 | MP0006082_CNS_inflammation | 1.51514446 |
| 33 | MP0003186_abnormal_redox_activity | 1.50991747 |
| 34 | MP0009643_abnormal_urine_homeostasis | 1.50971535 |
| 35 | MP0000609_abnormal_liver_physiology | 1.50430803 |
| 36 | MP0009764_decreased_sensitivity_to | 1.43900032 |
| 37 | MP0002118_abnormal_lipid_homeostasis | 1.39600165 |
| 38 | MP0003091_abnormal_cell_migration | 1.39499182 |
| 39 | MP0005503_abnormal_tendon_morphology | 1.38517669 |
| 40 | MP0001533_abnormal_skeleton_physiology | 1.37524830 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.34124616 |
| 42 | MP0002419_abnormal_innate_immunity | 1.34077357 |
| 43 | MP0003183_abnormal_peptide_metabolism | 1.33800807 |
| 44 | MP0001958_emphysema | 1.33411374 |
| 45 | MP0001835_abnormal_antigen_presentation | 1.29849217 |
| 46 | MP0009384_cardiac_valve_regurgitation | 1.29657274 |
| 47 | MP0003690_abnormal_glial_cell | 1.25104386 |
| 48 | MP0003279_aneurysm | 1.24460996 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.23631079 |
| 50 | MP0003828_pulmonary_edema | 1.21335992 |
| 51 | MP0005165_increased_susceptibility_to | 1.21143723 |
| 52 | MP0000015_abnormal_ear_pigmentation | 1.20805402 |
| 53 | MP0003045_fibrosis | 1.20753875 |
| 54 | MP0010368_abnormal_lymphatic_system | 1.19745710 |
| 55 | MP0003172_abnormal_lysosome_physiology | 1.19714431 |
| 56 | MP0002060_abnormal_skin_morphology | 1.19312809 |
| 57 | MP0008469_abnormal_protein_level | 1.17738028 |
| 58 | MP0010678_abnormal_skin_adnexa | 1.17568581 |
| 59 | MP0005171_absent_coat_pigmentation | 1.16689046 |
| 60 | MP0006054_spinal_hemorrhage | 1.13175302 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.12238657 |
| 62 | MP0010386_abnormal_urinary_bladder | 1.11530770 |
| 63 | MP0003566_abnormal_cell_adhesion | 1.11143782 |
| 64 | MP0009785_altered_susceptibility_to | 1.10990833 |
| 65 | MP0000604_amyloidosis | 1.10521941 |
| 66 | MP0001915_intracranial_hemorrhage | 1.08175714 |
| 67 | MP0002090_abnormal_vision | 1.08156737 |
| 68 | MP0004272_abnormal_basement_membrane | 1.07399392 |
| 69 | MP0005464_abnormal_platelet_physiology | 1.07257986 |
| 70 | MP0005408_hypopigmentation | 1.07150797 |
| 71 | MP0000343_altered_response_to | 1.06545597 |
| 72 | MP0003634_abnormal_glial_cell | 1.04794211 |
| 73 | MP0002295_abnormal_pulmonary_circulatio | 1.03665452 |
| 74 | MP0002877_abnormal_melanocyte_morpholog | 1.03504966 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.03457256 |
| 76 | MP0002332_abnormal_exercise_endurance | 1.02997515 |
| 77 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.02967513 |
| 78 | MP0001756_abnormal_urination | 1.02648678 |
| 79 | MP0005023_abnormal_wound_healing | 1.02392812 |
| 80 | MP0004947_skin_inflammation | 1.02121447 |
| 81 | MP0003633_abnormal_nervous_system | 1.00281151 |
| 82 | MP0003448_altered_tumor_morphology | 0.99877537 |
| 83 | MP0002998_abnormal_bone_remodeling | 0.99713907 |
| 84 | MP0005164_abnormal_response_to | 0.99215385 |
| 85 | MP0000858_altered_metastatic_potential | 0.98995486 |
| 86 | MP0002136_abnormal_kidney_physiology | 0.98967762 |
| 87 | MP0009763_increased_sensitivity_to | 0.97707629 |
| 88 | MP0000371_diluted_coat_color | 0.96039472 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.95777324 |
| 90 | MP0000598_abnormal_liver_morphology | 0.95341914 |
| 91 | MP0001851_eye_inflammation | 0.94636730 |
| 92 | MP0004782_abnormal_surfactant_physiolog | 0.94116868 |
| 93 | MP0005025_abnormal_response_to | 0.92780752 |
| 94 | MP0004484_altered_response_of | 0.92008604 |
| 95 | MP0003075_altered_response_to | 0.91974796 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.90406349 |
| 97 | MP0001542_abnormal_bone_strength | 0.89621751 |
| 98 | MP0003453_abnormal_keratinocyte_physiol | 0.88390572 |
| 99 | MP0002168_other_aberrant_phenotype | 0.87657237 |
| 100 | MP0005390_skeleton_phenotype | 0.87077649 |
| 101 | MP0001764_abnormal_homeostasis | 0.85469740 |
| 102 | MP0003632_abnormal_nervous_system | 0.85454380 |
| 103 | MP0005220_abnormal_exocrine_pancreas | 0.82440016 |
| 104 | MP0005167_abnormal_blood-brain_barrier | 0.81671777 |
| 105 | MP0005000_abnormal_immune_tolerance | 0.80717768 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.80070506 |
| 107 | MP0003303_peritoneal_inflammation | 0.79968289 |
| 108 | MP0002928_abnormal_bile_duct | 0.79935662 |
| 109 | MP0005397_hematopoietic_system_phenotyp | 0.79436367 |
| 110 | MP0001545_abnormal_hematopoietic_system | 0.79436367 |
| 111 | MP0000747_muscle_weakness | 0.78678131 |
| 112 | MP0005387_immune_system_phenotype | 0.78646430 |
| 113 | MP0001790_abnormal_immune_system | 0.78646430 |
| 114 | MP0005636_abnormal_mineral_homeostasis | 0.78640522 |
| 115 | MP0004510_myositis | 0.77455705 |
| 116 | MP0005174_abnormal_tail_pigmentation | 0.77212734 |
| 117 | MP0005166_decreased_susceptibility_to | 0.77003346 |
| 118 | MP0002933_joint_inflammation | 0.76556912 |
| 119 | MP0001243_abnormal_dermal_layer | 0.76336655 |
| 120 | MP0000767_abnormal_smooth_muscle | 0.75475990 |
| 121 | MP0001853_heart_inflammation | 0.73691738 |
| 122 | MP0005451_abnormal_body_composition | 0.72797364 |
| 123 | MP0004381_abnormal_hair_follicle | 0.72724438 |
| 124 | MP0003868_abnormal_feces_composition | 0.71829509 |
| 125 | MP0005409_darkened_coat_color | 0.71720487 |
| 126 | MP0004130_abnormal_muscle_cell | 0.71511872 |
| 127 | MP0009697_abnormal_copulation | 0.71238814 |
| 128 | MP0002166_altered_tumor_susceptibility | 0.71217464 |
| 129 | MP0000249_abnormal_blood_vessel | 0.70554385 |
| 130 | MP0004883_abnormal_blood_vessel | 0.70351798 |
| 131 | MP0003011_delayed_dark_adaptation | 0.70150922 |
| 132 | MP0003795_abnormal_bone_structure | 0.68714574 |
| 133 | MP0005257_abnormal_intraocular_pressure | 0.68626416 |
| 134 | MP0001661_extended_life_span | 0.65535166 |
| 135 | * MP0009642_abnormal_blood_homeostasis | 0.65080755 |
| 136 | MP0000685_abnormal_immune_system | 0.64059067 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.64000338 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 5.76919934 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 5.76919934 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 5.76919934 |
| 4 | Deep venous thrombosis (HP:0002625) | 4.54273206 |
| 5 | Xanthomatosis (HP:0000991) | 4.53678864 |
| 6 | Complement deficiency (HP:0004431) | 4.38186396 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.37902907 |
| 8 | Intrahepatic cholestasis (HP:0001406) | 4.36322517 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 4.22297683 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.03949084 |
| 11 | Prolonged partial thromboplastin time (HP:0003645) | 3.75804481 |
| 12 | Vacuolated lymphocytes (HP:0001922) | 3.62673157 |
| 13 | Joint hemorrhage (HP:0005261) | 3.62431847 |
| 14 | Myocardial infarction (HP:0001658) | 3.62187504 |
| 15 | Neurofibrillary tangles (HP:0002185) | 3.57595664 |
| 16 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.57342591 |
| 17 | Loss of speech (HP:0002371) | 3.52949926 |
| 18 | Abnormality of complement system (HP:0005339) | 3.46949253 |
| 19 | Hyperlipoproteinemia (HP:0010980) | 3.46446012 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.42750477 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.40230873 |
| 22 | Glomerulonephritis (HP:0000099) | 3.26998747 |
| 23 | Epidermoid cyst (HP:0200040) | 2.98407656 |
| 24 | Hypoglycemic coma (HP:0001325) | 2.95052543 |
| 25 | Increased CSF protein (HP:0002922) | 2.91651073 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 2.90014989 |
| 27 | Abnormality of the intrinsic pathway (HP:0010989) | 2.87079868 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.84991970 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.84991970 |
| 30 | Fat malabsorption (HP:0002630) | 2.84818069 |
| 31 | Axonal loss (HP:0003447) | 2.82974334 |
| 32 | Dysostosis multiplex (HP:0000943) | 2.81980632 |
| 33 | Hypobetalipoproteinemia (HP:0003563) | 2.79471918 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.79456607 |
| 35 | Eczematoid dermatitis (HP:0000976) | 2.73853072 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 2.73416480 |
| 37 | Hydroxyprolinuria (HP:0003080) | 2.73416480 |
| 38 | Increased cerebral lipofuscin (HP:0011813) | 2.71848696 |
| 39 | Cardiovascular calcification (HP:0011915) | 2.70811785 |
| 40 | Mitral stenosis (HP:0001718) | 2.68758321 |
| 41 | Hyperammonemia (HP:0001987) | 2.68455718 |
| 42 | Hypolipoproteinemia (HP:0010981) | 2.67970626 |
| 43 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.66770311 |
| 44 | Vascular calcification (HP:0004934) | 2.65673470 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.65173929 |
| 46 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.63625118 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63594314 |
| 48 | Progressive neurologic deterioration (HP:0002344) | 2.63539928 |
| 49 | Nuclear cataract (HP:0100018) | 2.63457555 |
| 50 | Hyperglycinuria (HP:0003108) | 2.60900859 |
| 51 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.59650565 |
| 52 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.59650565 |
| 53 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.59650565 |
| 54 | Ketosis (HP:0001946) | 2.59244469 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.57144939 |
| 56 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.55313668 |
| 57 | Nephritis (HP:0000123) | 2.53640610 |
| 58 | Premature rupture of membranes (HP:0001788) | 2.53052800 |
| 59 | Cervical subluxation (HP:0003308) | 2.51952502 |
| 60 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.50232775 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.50063735 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.50063735 |
| 63 | Skin nodule (HP:0200036) | 2.45258383 |
| 64 | Hepatocellular carcinoma (HP:0001402) | 2.40976993 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.38716936 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.38716936 |
| 67 | Peritonitis (HP:0002586) | 2.37154529 |
| 68 | Abnormality of nucleobase metabolism (HP:0010932) | 2.36304349 |
| 69 | Arterial tortuosity (HP:0005116) | 2.35850514 |
| 70 | Recurrent bacterial skin infections (HP:0005406) | 2.35395720 |
| 71 | Follicular hyperkeratosis (HP:0007502) | 2.35241364 |
| 72 | Conjugated hyperbilirubinemia (HP:0002908) | 2.33489141 |
| 73 | Generalized aminoaciduria (HP:0002909) | 2.30586111 |
| 74 | Steatorrhea (HP:0002570) | 2.29728419 |
| 75 | Vascular tortuosity (HP:0004948) | 2.23812987 |
| 76 | Hyperglycinemia (HP:0002154) | 2.23053076 |
| 77 | Gout (HP:0001997) | 2.22854393 |
| 78 | Protrusio acetabuli (HP:0003179) | 2.22236457 |
| 79 | Ketoacidosis (HP:0001993) | 2.22139345 |
| 80 | Abnormality of macrophages (HP:0004311) | 2.21647457 |
| 81 | Esophageal varix (HP:0002040) | 2.21021955 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 2.20147921 |
| 83 | Amyloidosis (HP:0011034) | 2.20100365 |
| 84 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.18410605 |
| 85 | Atrophic scars (HP:0001075) | 2.12474302 |
| 86 | Recurrent abscess formation (HP:0002722) | 2.11571201 |
| 87 | Spondylolisthesis (HP:0003302) | 2.09398519 |
| 88 | Protuberant abdomen (HP:0001538) | 2.08694406 |
| 89 | Disinhibition (HP:0000734) | 2.08343845 |
| 90 | Supranuclear gaze palsy (HP:0000605) | 2.08214097 |
| 91 | Hyporeflexia of lower limbs (HP:0002600) | 2.07754966 |
| 92 | Gingival bleeding (HP:0000225) | 2.06758461 |
| 93 | Right ventricular cardiomyopathy (HP:0011663) | 2.00456563 |
| 94 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.99585677 |
| 95 | Postural tremor (HP:0002174) | 1.99443862 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 1.98773327 |
| 97 | Nausea (HP:0002018) | 1.97074203 |
| 98 | Prolonged neonatal jaundice (HP:0006579) | 1.96726384 |
| 99 | Proximal tubulopathy (HP:0000114) | 1.96469585 |
| 100 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.96307648 |
| 101 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96082157 |
| 102 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94623169 |
| 103 | Global brain atrophy (HP:0002283) | 1.92412045 |
| 104 | Beaking of vertebral bodies (HP:0004568) | 1.91994600 |
| 105 | Elevated alkaline phosphatase (HP:0003155) | 1.90343619 |
| 106 | Vertebral compression fractures (HP:0002953) | 1.87874799 |
| 107 | Hypoglycemic seizures (HP:0002173) | 1.87322692 |
| 108 | Pathologic fracture (HP:0002756) | 1.85050924 |
| 109 | Mutism (HP:0002300) | 1.84823817 |
| 110 | Hematochezia (HP:0002573) | 1.84749075 |
| 111 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.84083185 |
| 112 | Tetraparesis (HP:0002273) | 1.83052389 |
| 113 | Pancreatitis (HP:0001733) | 1.82992441 |
| 114 | Autoamputation (HP:0001218) | 1.81930740 |
| 115 | Episodic fever (HP:0001954) | 1.81417944 |
| 116 | Scanning speech (HP:0002168) | 1.80858401 |
| 117 | Abnormality of the lumbar spine (HP:0100712) | 1.80760799 |
| 118 | Hyperbilirubinemia (HP:0002904) | 1.80487478 |
| 119 | Papillary thyroid carcinoma (HP:0002895) | 1.80234880 |
| 120 | J-shaped sella turcica (HP:0002680) | 1.79696930 |
| 121 | Apathy (HP:0000741) | 1.78176875 |
| 122 | Ovoid vertebral bodies (HP:0003300) | 1.78005824 |
| 123 | Diminished motivation (HP:0000745) | 1.75268162 |
| 124 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73950693 |
| 125 | Patchy hypopigmentation of hair (HP:0011365) | 1.73818775 |
| 126 | Abnormal cartilage morphology (HP:0002763) | 1.73653555 |
| 127 | Interstitial pulmonary disease (HP:0006530) | 1.72976909 |
| 128 | Orchitis (HP:0100796) | 1.72720804 |
| 129 | Autoimmune thrombocytopenia (HP:0001973) | 1.72521849 |
| 130 | Action tremor (HP:0002345) | 1.71642034 |
| 131 | Menorrhagia (HP:0000132) | 1.70261006 |
| 132 | Purpura (HP:0000979) | 1.68869227 |
| 133 | Periodontitis (HP:0000704) | 1.68602505 |
| 134 | Hemorrhage of the eye (HP:0011885) | 1.67991708 |
| 135 | Thick nail (HP:0001805) | 1.67622923 |
| 136 | Onycholysis (HP:0001806) | 1.66587587 |
| 137 | White forelock (HP:0002211) | 1.66148908 |
| 138 | Alopecia of scalp (HP:0002293) | 1.66128916 |
| 139 | Albinism (HP:0001022) | 1.65979630 |
| 140 | * Cardiomegaly (HP:0001640) | 1.65953871 |
| 141 | Popliteal pterygium (HP:0009756) | 1.64845087 |
| 142 | Muscle fibrillation (HP:0010546) | 1.64803172 |
| 143 | Hepatosplenomegaly (HP:0001433) | 1.64801495 |
| 144 | Lower limb hyperreflexia (HP:0002395) | 1.63486337 |
| 145 | Cerebral aneurysm (HP:0004944) | 1.62650486 |
| 146 | Neuronal loss in central nervous system (HP:0002529) | 1.59580917 |
| 147 | Plantar hyperkeratosis (HP:0007556) | 1.57570477 |
| 148 | Aortic dissection (HP:0002647) | 1.57297429 |
| 149 | Hypoplasia of the iris (HP:0007676) | 1.54069959 |
| 150 | Subacute progressive viral hepatitis (HP:0006572) | 1.51017384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 3.65542166 |
| 2 | FGFR4 | 2.58857586 |
| 3 | MAP3K12 | 2.56919153 |
| 4 | FRK | 2.51572887 |
| 5 | EPHB1 | 2.46978488 |
| 6 | SIK1 | 2.43458084 |
| 7 | BCKDK | 2.31582278 |
| 8 | EIF2AK3 | 2.29025502 |
| 9 | MAP3K14 | 2.26847601 |
| 10 | TGFBR2 | 2.22350038 |
| 11 | TYK2 | 2.20361779 |
| 12 | NEK9 | 2.18961363 |
| 13 | EPHA3 | 2.18128433 |
| 14 | MST1R | 2.14719888 |
| 15 | TAOK3 | 2.13279909 |
| 16 | IRAK3 | 1.98459856 |
| 17 | LATS1 | 1.93076324 |
| 18 | LIMK1 | 1.91711170 |
| 19 | TBK1 | 1.84503026 |
| 20 | SIK3 | 1.84259565 |
| 21 | BMPR2 | 1.82552791 |
| 22 | MOS | 1.76466314 |
| 23 | ARAF | 1.75923046 |
| 24 | PBK | 1.70443947 |
| 25 | TRIB3 | 1.67981632 |
| 26 | JAK1 | 1.66445638 |
| 27 | PIK3CG | 1.65933457 |
| 28 | INSRR | 1.65523504 |
| 29 | TRPM7 | 1.60222066 |
| 30 | KSR2 | 1.57792193 |
| 31 | TESK1 | 1.56565206 |
| 32 | KIT | 1.52950888 |
| 33 | MET | 1.51890923 |
| 34 | PTK6 | 1.47724982 |
| 35 | MAP3K3 | 1.46885352 |
| 36 | EIF2AK1 | 1.43635061 |
| 37 | FLT3 | 1.42731762 |
| 38 | PLK2 | 1.37678714 |
| 39 | MAP3K13 | 1.34766738 |
| 40 | GRK7 | 1.28501979 |
| 41 | JAK3 | 1.28216342 |
| 42 | STK3 | 1.23942913 |
| 43 | RIPK1 | 1.23195533 |
| 44 | YES1 | 1.22230231 |
| 45 | IRAK4 | 1.20741404 |
| 46 | WNK4 | 1.20676391 |
| 47 | FGFR3 | 1.20414131 |
| 48 | KSR1 | 1.17769761 |
| 49 | DDR2 | 1.16960188 |
| 50 | BLK | 1.13812387 |
| 51 | IKBKE | 1.12964057 |
| 52 | PDGFRA | 1.09738337 |
| 53 | NUAK1 | 1.09294560 |
| 54 | ABL2 | 1.09036469 |
| 55 | PKN2 | 1.08926247 |
| 56 | ERBB4 | 1.07140604 |
| 57 | CAMK1D | 1.05504814 |
| 58 | IKBKB | 1.05416298 |
| 59 | PIM2 | 1.03945327 |
| 60 | JAK2 | 1.03651991 |
| 61 | TTN | 1.02529179 |
| 62 | ROCK2 | 1.02374826 |
| 63 | PAK6 | 0.99552768 |
| 64 | MAP2K3 | 0.98762761 |
| 65 | MAPK15 | 0.96905949 |
| 66 | CHUK | 0.96821468 |
| 67 | PAK3 | 0.95767899 |
| 68 | MST4 | 0.95192433 |
| 69 | BCR | 0.92399357 |
| 70 | CDK6 | 0.92338827 |
| 71 | FGFR2 | 0.90390452 |
| 72 | LATS2 | 0.89762258 |
| 73 | CSF1R | 0.87682107 |
| 74 | PTK2 | 0.87340589 |
| 75 | LMTK2 | 0.87114404 |
| 76 | RAF1 | 0.86758488 |
| 77 | CSK | 0.85986718 |
| 78 | LRRK2 | 0.83118442 |
| 79 | NEK6 | 0.82283442 |
| 80 | MAP3K2 | 0.78984366 |
| 81 | EPHB2 | 0.78919201 |
| 82 | BMX | 0.78420483 |
| 83 | TRIM28 | 0.78269329 |
| 84 | TIE1 | 0.76621031 |
| 85 | FER | 0.73171927 |
| 86 | STK38 | 0.72913917 |
| 87 | GSK3A | 0.72861102 |
| 88 | IRAK1 | 0.71238021 |
| 89 | ERBB3 | 0.70791309 |
| 90 | ZAP70 | 0.70174255 |
| 91 | CAMK2D | 0.68902218 |
| 92 | BMPR1B | 0.67474730 |
| 93 | PDGFRB | 0.65158754 |
| 94 | NTRK1 | 0.64854995 |
| 95 | STK38L | 0.64690402 |
| 96 | DAPK2 | 0.64218952 |
| 97 | CAMKK2 | 0.62033145 |
| 98 | IGF1R | 0.61811631 |
| 99 | PRKCE | 0.61807743 |
| 100 | STK10 | 0.60015256 |
| 101 | TEC | 0.59091560 |
| 102 | ABL1 | 0.58736777 |
| 103 | ACVR1B | 0.58623160 |
| 104 | SGK3 | 0.58075281 |
| 105 | RIPK4 | 0.57077005 |
| 106 | OXSR1 | 0.56156444 |
| 107 | PHKG2 | 0.55977977 |
| 108 | PHKG1 | 0.55977977 |
| 109 | RPS6KA4 | 0.55831223 |
| 110 | STK39 | 0.55792193 |
| 111 | MAP2K6 | 0.55659492 |
| 112 | TNK2 | 0.55527972 |
| 113 | MAPK11 | 0.55202393 |
| 114 | PTK2B | 0.55026550 |
| 115 | DYRK1B | 0.54521093 |
| 116 | CAMK2G | 0.53469419 |
| 117 | BTK | 0.50829305 |
| 118 | ERBB2 | 0.50651691 |
| 119 | PIK3CA | 0.49890008 |
| 120 | WNK3 | 0.49701386 |
| 121 | NLK | 0.49541047 |
| 122 | PRPF4B | 0.49485948 |
| 123 | FGR | 0.48789681 |
| 124 | PDPK1 | 0.48731504 |
| 125 | EGFR | 0.48425493 |
| 126 | ITK | 0.48122478 |
| 127 | ROCK1 | 0.47270487 |
| 128 | PRKAA2 | 0.47219388 |
| 129 | MAP3K9 | 0.46994331 |
| 130 | MAPKAPK2 | 0.46807479 |
| 131 | ZAK | 0.45834870 |
| 132 | KDR | 0.44101701 |
| 133 | SCYL2 | 0.43956171 |
| 134 | MATK | 0.43471126 |
| 135 | MAP3K1 | 0.42918613 |
| 136 | EPHA2 | 0.41326505 |
| 137 | PRKCD | 0.40400573 |
| 138 | TGFBR1 | 0.40108992 |
| 139 | LYN | 0.40103605 |
| 140 | PAK4 | 0.39464397 |
| 141 | MAP2K2 | 0.39386482 |
| 142 | HCK | 0.37978772 |
| 143 | MYLK | 0.37935584 |
| 144 | PDK2 | 0.36868988 |
| 145 | PAK2 | 0.36851662 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.32025559 |
| 2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.05280244 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.78601028 |
| 4 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.66297477 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65425909 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.60006336 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.23169647 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22194079 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14112528 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.02972883 |
| 11 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02777078 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.00696532 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.97229533 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.93602997 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.93428323 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89028700 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.80212533 |
| 18 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.78635803 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.77769818 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75807082 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.70936674 |
| 22 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68392784 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.67441196 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.62260851 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.55398910 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54784662 |
| 27 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53006685 |
| 28 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.52737929 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50179495 |
| 30 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.48278589 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.47977972 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.47650299 |
| 33 | Retinol metabolism_Homo sapiens_hsa00830 | 1.46258183 |
| 34 | * Lysosome_Homo sapiens_hsa04142 | 1.43057570 |
| 35 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.26659756 |
| 36 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.24949091 |
| 37 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.24898197 |
| 38 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24560892 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23337223 |
| 40 | Other glycan degradation_Homo sapiens_hsa00511 | 1.22825930 |
| 41 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.20097835 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.17749887 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.15247038 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.14839558 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12614740 |
| 46 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.11264849 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.08741385 |
| 48 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06119275 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04564846 |
| 50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.02133380 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.94187059 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 0.91053514 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.90526486 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89299464 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.88645071 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85251046 |
| 57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.85012952 |
| 58 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84298130 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.81699823 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.79800650 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.79085332 |
| 62 | Shigellosis_Homo sapiens_hsa05131 | 0.77258185 |
| 63 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76928967 |
| 64 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76008672 |
| 65 | Pertussis_Homo sapiens_hsa05133 | 0.75750059 |
| 66 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.72407200 |
| 67 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.72342736 |
| 68 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.71847669 |
| 69 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.71339226 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71166619 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.69165301 |
| 72 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67863271 |
| 73 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.66664185 |
| 74 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.65045293 |
| 75 | Lysine degradation_Homo sapiens_hsa00310 | 0.63586137 |
| 76 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63559441 |
| 77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.62952608 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61920342 |
| 79 | Endocytosis_Homo sapiens_hsa04144 | 0.60534247 |
| 80 | * Phagosome_Homo sapiens_hsa04145 | 0.60389937 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.59605610 |
| 82 | Prion diseases_Homo sapiens_hsa05020 | 0.58472332 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58366136 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.57888236 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.57838389 |
| 86 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.57802121 |
| 87 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.57005168 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.56904393 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.56449674 |
| 90 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55396569 |
| 91 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54078599 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.53592161 |
| 93 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52810227 |
| 94 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.51853850 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50514695 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48181876 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.47668394 |
| 98 | Insulin resistance_Homo sapiens_hsa04931 | 0.47295004 |
| 99 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.46740663 |
| 100 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46422681 |
| 101 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.46187247 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.44967398 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44899246 |
| 104 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44491545 |
| 105 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.43972513 |
| 106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.43672995 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.43467351 |
| 108 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42723820 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.42418802 |
| 110 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.40960563 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | 0.40758197 |
| 112 | * Tuberculosis_Homo sapiens_hsa05152 | 0.40567182 |
| 113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.39975714 |
| 114 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39844467 |
| 115 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.39550531 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.38632435 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.37824431 |
| 118 | Protein export_Homo sapiens_hsa03060 | 0.37701038 |
| 119 | Renin secretion_Homo sapiens_hsa04924 | 0.37628377 |
| 120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37465144 |
| 121 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36926721 |
| 122 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36722351 |
| 123 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.36707901 |
| 124 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36390327 |
| 125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.36046286 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35732910 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34560102 |
| 128 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.34105563 |
| 129 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.32870100 |
| 130 | Hepatitis C_Homo sapiens_hsa05160 | 0.31297979 |
| 131 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.30848500 |
| 132 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30615097 |
| 133 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30380075 |
| 134 | Sulfur relay system_Homo sapiens_hsa04122 | 0.28497962 |
| 135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27905006 |
| 136 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.26229621 |

